Assessment of ensuring radiation safety competence for release criteria following 125I prostate brachytherapy

Assessment of ensuring radiation safety competence for release criteria following 125I prostate brachytherapy - Assessment of ensuring radiation safety competence for release criteria following 125I prostate brachytherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018332

Enrollment

Registered

2015-07-16

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Written informed consent must be obtained from patients and their family members

Exclusion criteria

Exclusion criteria: 1) Patients less than 5 years life expectancy 2) Patients with distant metastases 3) Patients with metal allergy 4) Patients whom radiation therapy is contraindicated 5) Patients with bleeding 6) Patients with ascites, pleural effusion 7) Patients suspected with skin, pleura, peritoneum infection 8) Patients suspected with abscess, vascular disease 9) Patients who cannot be ensured a safe puncture route 10) Patients who cannot be transfused 11) Patients whom target site is confusing 12) Patients who are judged inappropriate for the clinical trial by doctors

Design outcomes

Primary

Measure	Time frame
Estimate lifetime exposure that patient's family members receive after the 125I prostate brachytherapy	—

Countries

Japan

Contacts

Public ContactAtsunori Yorozu

National Hospital Organization, Tokyo Medical Center Radiation Oncology

ayorozu@ntmc.hosp.go.jp03-3411-0111

Outcome results